CervoMed (CRVO) Revenue & Revenue Breakdown
CervoMed Revenue Highlights
Latest Revenue (Y)
$4.01M
CervoMed Revenue by Period
CervoMed Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $4.01M | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | 100.00% |
| 2015-12-31 | - | 100.00% |
| 2014-12-31 | - | -100.00% |
| 2013-12-31 | $71.67K | -80.87% |
| 2012-12-31 | $374.54K | -34.35% |
| 2011-12-31 | $570.48K | 1319.48% |
| 2010-12-31 | $40.19K | 100.00% |
| 2009-12-31 | - | -100.00% |
| 2008-12-31 | $40.19K | -86.98% |
| 2007-12-31 | $308.76K | 100.00% |
| 2006-12-31 | - | 100.00% |
| 2005-12-31 | - | -100.00% |
| 1999-12-31 | $26.94M | -3.49% |
| 1998-12-31 | $27.91M | - |
CervoMed generated $4.01M in revenue during NA 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
CervoMed Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-03-31 | - | 100.00% |
| 2025-12-31 | - | -100.00% |
| 2025-09-30 | $322.57K | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | 100.00% |
| 2024-12-31 | - | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | - |
CervoMed generated - in revenue during Q1 2026, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
CervoMed Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FBIO | Fortress Biotech | $61.24M | $15.92M |
| ADAG | Adagene | $18.11M | $833.34K |
| CRVO | CervoMed | $4.01M | - |
| NTRB | Nutriband | $2.04M | $433.40K |
| NRXP | NRx Pharmaceuticals | $1.23M | $1.07M |
| OSTX | OS Therapies | - | - |
| VTVT | vTv Therapeutics | - | $36.84M |
| ACET | Adicet Bio | - | - |
| XBIT | XBiotech | - | - |
| GANX | Gain Therapeutics | - | - |
| LITS | Lite Strategy | - | - |